BPG is committed to discovery and dissemination of knowledge
Articles in Press
4/19/2024 7:08:23 AM | Browse: 37 | Download: 0
Publication Name World Journal of Virology
Manuscript ID 90668
Country Congo
Category Cardiac & Cardiovascular Systems
Manuscript Type Randomized Clinical Trial
Article Title Hydroxychloroquine-azithromycin, doubase C, and QTc prolongation in congolese patients with COVID-19: Myth or reality?
Manuscript Source Unsolicited Manuscript
All Author List Brady Madioko Makanzu, Jean-Robert Makulo, Madone Ndona Mandina, Dimosi Roger Wumba, Murielle Mashi Longokolo, Hippolyte Situakibanza, Ossam Odio, Donat Sonzi Mangala, Constantin Mihigo Bashengezi, Benjamin Kabwe Mwilambwe, Gilbert Kabanda Kurhenga, Benjamin Longo-Mbenza and Roger Mwimba Mbungu
Funding Agency and Grant Number
Corresponding Author Brady Madioko Makanzu, MD, Doctor, Department of Cardiology, Kinshasa University Hospital, Kinshasa, DR Congo , Kinshasa University Hospital, Kimwenza Road, Lemba Municipality, Kinshasa City, Kinshasa 11, Congo. bmaknzu@gmail.com
Key Words QTc prolongation; COVID-19; Doubase C; HCQ-AZT; Sub-Saharan Africa
Core Tip During the coronavirus disease 2019 (COVID-19) pandemic, western studies have shown the ineffectiveness and cardiotoxic effects of hydroxychloriquine and azithromycin (HCQ-AZI). In Africa, the heart toxicity of HCQ-AZI is little reported by cardiologists, and some african countries used these two molecules to treat COVID-19 patients. In the present study, we have evaluated the occurrence of prolongation of the QTc interval and torsade de pointes torsade in Congolese COVID-19 patients who received HCQ-AZI compared to Doubase C, a herbal medicine with broad-spectrum antiviral activity.
Citation Madioko Makanzu B, Makulo JR, Ndona Mandina M, Wumba DR, Mashi Longokolo M, Situakibanza H, Odio O, Sonzi Mangala D, Mihigo Bashengezi C, Kabwe Mwilambwe B, Kabanda Kurhenga G, Longo-Mbenza B, Mwimba Mbungu R. Hydroxychloroquine-azithromycin, doubase C, and QTc prolongation in congolese patients with COVID-19: Myth or reality? World J Virol 2024; In press
Received
2023-12-18 15:42
Peer-Review Started
2023-12-10 18:58
To Make the First Decision
Return for Revision
2024-03-10 02:11
Revised
2024-04-05 19:57
Second Decision
2024-04-19 02:43
Accepted by Journal Editor-in-Chief
Accepted by Company Editor-in-Chief
2024-04-19 07:08
Articles in Press
2024-04-19 07:08
Publication Fee Transferred
Edit the Manuscript by Language Editor
Typeset the Manuscript
ISSN 2220-3249 (online)
Open Access This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/
Copyright ©The Author(s) 2024. Published by Baishideng Publishing Group Inc. All rights reserved.
Permissions For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
Publisher Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
Website http://www.wjgnet.com